These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 1638518)
21. Cytotoxic and biochemical implications of combining AZT and AG-331. Pressacco J; Mitrovski B; Erlichman C Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359 [TBL] [Abstract][Full Text] [Related]
23. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Benz C; Cadman E Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888 [TBL] [Abstract][Full Text] [Related]
24. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632 [TBL] [Abstract][Full Text] [Related]
25. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects. Pressacco J; Erlichman C Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649 [TBL] [Abstract][Full Text] [Related]
26. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. Miyachi H; Jiao L; Sowers LC; Scanlon KJ In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729 [TBL] [Abstract][Full Text] [Related]
27. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor. Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530 [TBL] [Abstract][Full Text] [Related]
28. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice. Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185 [TBL] [Abstract][Full Text] [Related]
29. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
30. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Aschele C; Sobrero A; Faderan MA; Bertino JR Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346 [TBL] [Abstract][Full Text] [Related]
31. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells. Darnowski JW; Davol PA; Goulette FA Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409 [TBL] [Abstract][Full Text] [Related]
32. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy. Bertino JR; Mini E; Fernandes DJ Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754 [TBL] [Abstract][Full Text] [Related]
33. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells. Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470 [TBL] [Abstract][Full Text] [Related]
34. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine. Gao WY; Johns DG; Tanaka M; Mitsuya H Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line. Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344 [TBL] [Abstract][Full Text] [Related]
36. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Rhee MS; Galivan J; Wright JE; Rosowsky A Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264 [TBL] [Abstract][Full Text] [Related]
37. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239 [TBL] [Abstract][Full Text] [Related]
38. [Biochemical modulation in cancer chemotherapy]. Kawasaki H; Nobori T; Kamiya H; Sakurai M Gan To Kagaku Ryoho; 1985 Apr; 12(4):815-29. PubMed ID: 3985645 [TBL] [Abstract][Full Text] [Related]
39. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells. Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987 [TBL] [Abstract][Full Text] [Related]
40. Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate. Mordoh J; Chacón RD; Filmus J Cancer Res; 1981 Sep; 41(9 Pt 1):3621-8. PubMed ID: 6942915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]